6 German Institute of Human Nutrition Potsdam-Rehbruecke Department of Epidemiology Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany. 7 WHO Collaborating Center for Food and Nutrition Policies, pp.75-115 ,
10 Bureau of Epidemiologic Research, Academy of Athens, Panepistimiou Street, vol.28, pp.106-79 ,
12 Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 13 Department of Clinical and Experimental Medicine, Federico II University 14 Cancer Registry and Histopathology Unit 17 Public Health and Health Planning Directorate, Asturias, Spain. 18 Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, Greece. 11 Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute ? ISPO 16 HuGeF Foundation Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública-CIBERESP), p.20, 1921. ,
Histological and molecular types of breast cancer: is there a unifying taxonomy?, Nature Reviews Clinical Oncology, vol.16, issue.12, pp.718-730, 2009. ,
DOI : 10.1038/nrclinonc.2009.166
Etiology of hormone receptor-defined breast cancer: a systematic review of the literature, Cancer Epidemiol Biomarkers Prev, issue.10, pp.131558-1568, 2004. ,
Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies, Breast Cancer Research, vol.15, issue.4, p.43, 2006. ,
DOI : 10.1016/j.tem.2004.05.011
Biologic and Clinical Characteristics of Breast Cancer With Single Hormone Receptor???Positive Phenotype, Journal of Clinical Oncology, vol.25, issue.30, pp.254772-4778, 2007. ,
DOI : 10.1200/JCO.2007.12.2747
Microarray-based Gene Expression Profiling as a Clinical Tool for Breast Cancer Management: Are We There Yet?, International Journal of Surgical Pathology, vol.17, issue.4, pp.285-302, 2008. ,
DOI : 10.1177/1066896908328577
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures, Breast Cancer Research, vol.6, issue.4, p.65, 2008. ,
DOI : 10.1038/nrc1802
Molecular portraits of human breast tumours, Nature, issue.6797, pp.406747-752, 2000. ,
Comparison of molecular phenotypes of ductal carcinoma in situand invasive breast cancer, Breast Cancer Research, vol.275, issue.4, p.67, 2008. ,
DOI : 10.1001/jama.1996.03530360023033
Breast Cancer Risk and Hormone Receptor Status in Older Women by Parity, Age of First Birth, and Breastfeeding: A Case-Control Study, Cancer Epidemiology Biomarkers & Prevention, vol.17, issue.7, pp.171723-1730, 2008. ,
DOI : 10.1158/1055-9965.EPI-07-2824
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies, JNCI Journal of the National Cancer Institute, vol.103, issue.3, pp.250-263, 2011. ,
DOI : 10.1093/jnci/djq526
Epidemiology of basal-like breast cancer, Breast Cancer Research and Treatment, vol.315, issue.1 Suppl, pp.123-139, 2008. ,
DOI : 10.1007/s10549-007-9632-6
Epidemiology of triple negative breast cancers, Breast Disease, vol.32, issue.1-2, pp.5-24, 2010. ,
DOI : 10.3233/BD-2010-0319
The shape of age-incidence curves of female breast cancer by hormone-receptor status, Cancer Causes and Control, vol.10, issue.5, pp.431-437, 1999. ,
DOI : 10.1023/A:1008970121595
Reproductive History and Oral Contraceptive Use in Relation to Risk of Triple-Negative Breast Cancer, JNCI Journal of the National Cancer Institute, vol.103, issue.6, pp.470-477, 2011. ,
DOI : 10.1093/jnci/djr030
Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer, Cancer, vol.109, issue.7, pp.1521-1526, 2008. ,
DOI : 10.1002/cncr.23786
The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition, International Journal of Epidemiology, vol.26, issue.90001, pp.6-14, 1997. ,
DOI : 10.1093/ije/26.suppl_1.S6
European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection, European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection, pp.1113-1124, 2002. ,
DOI : 10.1093/ije/26.suppl_1.S1
Age at Menarche in Relation to Adult Height: The EPIC Study, American Journal of Epidemiology, vol.162, issue.7, pp.162623-632, 2005. ,
DOI : 10.1093/aje/kwi260
Overweight, obesity and fat distribution in 50-to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC) Public Health Nutr, pp.1147-1162, 2002. ,
Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case?control study, Cancer Prev Res, vol.4, issue.10, pp.1626-1635, 2011. ,
Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study, Public Health Nutrition, vol.35, issue.04, pp.407-413, 2003. ,
DOI : 10.1093/ije/26.suppl_1.S181
Modeling Effects of Age at and Time Since Delivery on Subsequent Risk of Cancer, Epidemiology, vol.10, issue.6, pp.739-746, 1999. ,
DOI : 10.1097/00001648-199911000-00015
Applying Cox Regression to Competing Risks, Biometrics, vol.51, issue.2, pp.524-532, 1995. ,
DOI : 10.2307/2532940
Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study, Breast Cancer Research, vol.20, issue.Suppl 1, p.76 ,
DOI : 10.1093/annonc/mdp322
URL : https://hal.archives-ouvertes.fr/inserm-00704067
Breast Cancer Risk Factors Defined by Estrogen and Progesterone Receptor Status: The Multiethnic Cohort Study, American Journal of Epidemiology, vol.169, issue.10, pp.1691251-1259, 2009. ,
DOI : 10.1093/aje/kwp036
Breast cancer In Textbook of Cancer Epidemiology, pp.403-445 ,
al: Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: a cohort study ,
Some endocrine characteristics of early menarche, a risk factor for breast cancer, are preserved into adulthood, International Journal of Cancer, vol.9, issue.5 ,
DOI : 10.1002/ijc.2910440506
Hormone replacement therapy: pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: a mini-review, Human Reproduction, vol.20, issue.8, pp.2052-2060, 2005. ,
DOI : 10.1093/humrep/dei043
The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer, Breast Cancer Research, vol.6, issue.6, pp.240-245, 2004. ,
DOI : 10.1023/A:1011308707512
Control of mammary stem cell function by steroid hormone signalling, Nature, vol.21, issue.7299, pp.465798-802, 2010. ,
DOI : 10.1038/nature09027
Pregnancy-Induced Changes in Breast Cancer Risk, Journal of Mammary Gland Biology and Neoplasia, vol.30, issue.3, pp.221-233, 2011. ,
DOI : 10.1007/s10911-011-9228-y
Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case???control and a case???case comparison, Breast Cancer Research, vol.15, issue.4, p.39, 2006. ,
DOI : 10.1016/j.tem.2004.05.011
Risk Factors for Triple-Negative Breast Cancer in Women Under the Age of 45 Years, Cancer Epidemiology Biomarkers & Prevention, vol.18, issue.4, pp.1157-1166, 2009. ,
DOI : 10.1158/1055-9965.EPI-08-1005
Breast cancers among very young premenopausal women (United States) Cancer Causes Control, pp.151-160, 2003. ,
Oral, injected and implanted contraceptives and breast cancer risk among U.S. Hispanic and non-Hispanic white women, International Journal of Cancer, vol.106, issue.11 ,
DOI : 10.1002/ijc.22970
Oral Contraceptive Use and Estrogen/Progesterone Receptor-Negative Breast Cancer among African American Women, Cancer Epidemiology Biomarkers & Prevention, vol.19, issue.8, pp.2073-2079, 2010. ,
DOI : 10.1158/1055-9965.EPI-10-0428
Different clinical impact of estradiol receptor determination according to the analytical method: a study on 1940 breast cancer patients over a period of 16 consecutive years, Breast Cancer Research and Treatment, vol.117, issue.5, pp.95179-184, 2006. ,
DOI : 10.1007/s10549-005-9065-z
Comparison of Immunohistochemical and Biochemical Assay of Steroid Receptors in Primary Breast Cancer Clinical Associations and Reasons for Discrepancies, Acta Oncologica, vol.14, issue.7, pp.719-725, 2003. ,
DOI : 10.1038/bjc.1996.291
Standardization of Estrogen Receptor Measurement in Breast Cancer Suggests False-Negative Results Are a Function of Threshold Intensity Rather Than Percentage of Positive Cells, Journal of Clinical Oncology, vol.29, issue.22, pp.292978-2984, 2011. ,
DOI : 10.1200/JCO.2010.32.9706
Breast Cancer Testing Scandal Shines Spotlight on Black Box of Clinical Laboratory Testing, JNCI Journal of the National Cancer Institute, vol.100, issue.12, pp.836-837, 2008. ,
DOI : 10.1093/jnci/djn200
Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups, Cancer, vol.53, issue.Suppl, pp.37-45, 2001. ,
DOI : 10.1002/1097-0142(20010701)92:1<37::AID-CNCR1289>3.0.CO;2-F